Incuba Venture logo

Incuba Venture

Europe, Midtjylland, Denmark, Aarhus

Description

Incuba Venture makes early-stage investments in companies based in Denmark.

Investor Profile

Incuba Venture has made 5 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (60%)
  • Series A (20%)
  • Series B (20%)

Country Focus

  • Denmark (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Web Hosting
  • Health Diagnostics
  • Dietary Supplements
  • Natural Resources
  • Oncology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Incuba Venture frequently co-invest with?

Vecata
Europe, Syddanmark, Denmark, Vejle
Co-Investments: 3
Aravis Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
NM
Europe, Nordjylland, Denmark, Aalborg
Co-Investments: 1
Seventure Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 1
AA
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 1
BankInvest
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 1

What are some of recent deals done by Incuba Venture?

Anapa Biotech

Hvidovre, Hovedstaden, Denmark

Anapa Biotech, formerly QuantiBact, is a biotech company developing molecular tools to enhance the performance of natural nucleic acids.

BiotechnologyHealth CareHealth Diagnostics
Series UnknownJan 25, 2007
Amount Raised: $1,000,000
v2tel

Taastrup, Hovedstaden, Denmark

v2tel is a Denmark-based company acquired by SuperTel Danmark.

Web Hosting
Series UnknownDec 21, 2006
Amount Raised: $3,530,000
Fluxome

Stenløse, Hovedstaden, Denmark

Fluxome produces pure and natural resveratrol with ingredients that give beneficial effects to human health.

BiotechnologyDietary SupplementsNatural Resources
Series UnknownNov 30, 2005
Amount Raised: $7,200,000
Borean Pharma

Aarhus, Midtjylland, Denmark

Borean Pharma ApS operates as a drug discovery and development company.

Biotechnology
Series AMar 23, 2005
Amount Raised: $5,198,897
LiPlasome Pharma

Vejle, Syddanmark, Denmark

LiPlasome, a biotech company focused on oncology, provides a liplasomal reformulation of anticancer drugs on the market.

BiotechnologyHealth CareOncologyPharmaceutical
Series BMar 1, 2005
Amount Raised: $8,010,000